API and Formulation Section
RBPL has set up a state-of-the-art facility to manufacture active pharmaceutical ingredients and to further formulate them into encapsulated drug products. The facility focuses primarily on development and manufacturing of clinical trial materials under GMP guidelines.
RBPL has set up of state-of-the-art pilot up facility approved by state DSIR for manufacture of API and formulations.
This approved facility has distinctly seperate sections under controlled environment. These sections compliment each other and have been approved by regulatory body.
API Manufacturing
Involves a wide array of complex chemical or biological processes.
RBPL’s Manufacturing Facility is uniquely placed to generate samples for Clinical Trials and is perhaps one of the few dedicated facilities attached to a R & D Center.